Peter Radovich, See Remarks at Global Blood Therapeutics, Inc. (GBT), sold 2,404 shares at $57.30 ($140K) on 2018-02-01, disclosed to the SEC on 2018-02-02.
Scheduled sale ($140k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.90 | 554 | $32K | 22.8% |
| 2 | $57.30 | 812 | $47K | 33.1% |
| 3 | $59.60 | 1,038 | $62K | 44.0% |
| Total | $58.43 avg | 2,404 | $140K | 100% |
| Filing → |
| MIRM | SELL | 2026-01-27 | $302K | — | Filing → |
| MIRM | SELL | 2026-01-23 | $222K | — | Filing → |
| MIRM | SELL | 2025-03-18 | $697K | — | Filing → |